Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2

Science in China, Series C: Life Sciences

Volumn 50, Issue 2, 2007, Pages 203-211

  Weng, XiuFang ^a   Liang, ZhiHui ^a   Lu, XiaoLing ^a   Zhong, MaoHua ^a   Lu, ShengJun ^a   Zhang, CaiE ^a   Deng, Jing ^a   Wu, XiongWen ^a   Gong, FeiLi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alloreactive T cells; Long term mixed lymphocytes culture (LTMLC); Peptide specific; Peptide MHC complex

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; PEPTIDE; VIRUS PROTEIN;

ARTICLE; CELL LINE; CHEMISTRY; CYTOTOXICITY; HUMAN; IMMUNOLOGY; MACROMOLECULE; MAJOR HISTOCOMPATIBILITY COMPLEX; T LYMPHOCYTE;

ANTIGENS, CD8; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; MACROMOLECULAR SUBSTANCES; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; T-LYMPHOCYTES; VIRAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34247359881     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-007-0036-y     Document Type: Article

References (36)

1. Hornick P. Direct and indirect allorecognition. Methods Mol Biol, 2006, 333: 145-156
2. Benichou G, Valujskikh A, heeger P S. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol, 1999, 162: 352-358
3. Whitelegg A, Barber L D. The structural basis of T-cell allorecognition. Tissue Antigens, 2004, 63: 101-108
4. Suchin E J, Langmuir P B, Palmer E, et al. Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol, 2001, 166: 973-981
5. Elliott T J, Eisen H N. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc Natl Acad Sci USA, 1990, 87: 5213-5217
6. Jankovic V, Jankovic V, Remus K, et al. T cell recognition of an engineerd MHC class I molecule: implication for peptide-independent alloreactivity. J Immunol, 2002, 169: 1887-1892
7. Smith P A, Brunmark A, Jackson M R, et al. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J Exp Med, 1997, 185: 1023-1033
8. Whitelegg A M, Oosten L E, Jordan S, et al. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. J Immunol, 2005, 175(3): 1706-1714
9. Wang W, Man S, Gulden P H, et al. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J Immunol, 1998, 160: 1091-1097
10. Moris A, Teichraber V, Gauthier L, et al. Cutting edge: Characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection. J Immunol, 2001, 166: 4818-4821
11. Matzinger P, Bevan M J. Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol, 1977, 29: 1-5
12. Mosse C A, Meadows L, Luckey C J, et al. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med, 1998, 187(1): 37-48
13. Murray G P, Constandinon C M, Crocker J, et al. Analysis of major histocompatibility complex class I, Tap expression, and LMP2 epitope sequence in Epstein-Barr virus positive hodgkin's disease. Blood, 1998, 92(7): 2477-2483
14. June K M, Bryida B, Flossie W S, et al. The HIV-1 HLA-A2-ve SLYNTVATL is a help-independent CTL epitope. J Immunol, 2004, 172: 5249-5261
15. Cerundolo V J, Alexander K, Anderson C, et al. Presentation of viral antigen controlled by a gene in the major histocopatibility complex. Nature, 1990, 345: 449-452
16. Luft T, Rizkalla M, Tai T, et al. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation. J Immunol, 2001, 167(5): 2529-2537
17. Bunce M, O'Neill C M, Barnardo M C, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 1995, 46: 355-367
18. Garboczi D N, Hung D T, Wiley D C, et al. HLA-A2-ve peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexes with single antigenic peptides. Proc Natl Acad Sci USA, 1992, 89(8): 3429-3433
19. Altman J D, Moss P A, Goulder P J, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science, 1996, 274: 94-96
20. Ocallaghan C A, Byford M F, Wyer J R, et al. BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal Biochem, 1999, 266(1): 9-15
21. Van J G, Cardine L P, Laiten R M. T-cell avidity and tuning: the flexible connection between tolerance and autoimmunity. Int Rev Immunol, 2006, 25(3): 235-258
22. Zinkemagel R M, Doherty P C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature, 1974, 248: 701-702
23. Crumpacker D B, Alexander J, Cresswell P, et al. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J Immunol, 1992, 148: 3004-3011
24. Koster H S, Vermeulen C J, Koning F. The majority of HLA-DR3 alloreactive T cells is peptide specific, but does not recognize known DR3-bound sequences. Tissue Antigens, 1998, 51: 88-95
25. Heath W R, Hurd M E, Carbone F R, et al. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature, 1989, 342: 749-752
26. Rotzschke O, Falk K, Faath S, et al. On the nature of peptides involved in T cell alloreactivity. J Exp Med, 1991, 174: 1059-1071
27. Kuzushima K, Sun R, van Bleek G M, et al. The role of self peptides in the allogeneic cross-reactivity of CTLs. J Immunol, 1995, 155: 594-560
28. Wang W, Gulden P H, Pierce R A, et al. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity. J Immunol, 1997, 158: 5797-5804
29. Malarkannan S, Afkarian M, Shastri N. A rare cryptic translation product is presented by Kb major histocompatiblity complex class I molecule to alloreactive T cells. J Exp Med, 1995, 182: 1739-1750
30. Felix N J, Suri A, Walters J J, et al. I-Ep-bound self-peptides: identification, characterization, and role in alloreactivity. J Immunol, 2006, 176(2): 1062-1071
31. Obst R, Netuschil N, Klopfer B. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J Exp Med, 2000, 191: 805-812
32. Sadovnikova E, Jopling L A, Soo K S, et al. Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur J Immunol, 1998, 28: 193-200
33. Yee C, Savage P A, Lee P P, et al. Isolation of high avidity melanomareactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol, 1999, 162: 2227-2234
34. Mackinnon S, Papadopoulos E B, Carabasi M H, et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 1995, 86: 1261-1268
35. Pittet M J, Gati A, Legal F A, et al. Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex. J Immunol, 2006, 176(4): 2330-2336
36. Ruan X G, Li Y X, Li J G, et al. Tumor-specific gene expression patterns with gene expression profiles. Sci China Ser C-Life Sci, 2006, 49(3): 293-304